CAPTRUST Financial Advisors’s AIM ImmunoTech AIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-200
Closed -$2.45K 2610
2025
Q1
$2.45K Hold
200
﹤0.01% 2349
2024
Q4
$3.96K Hold
200
﹤0.01% 2288
2024
Q3
$5.4K Hold
200
﹤0.01% 2282
2024
Q2
$7.45K Hold
200
﹤0.01% 2190
2024
Q1
$9.42K Hold
200
﹤0.01% 2127
2023
Q4
$8.8K Hold
200
﹤0.01% 2634
2023
Q3
$9.1K Hold
200
﹤0.01% 2539
2023
Q2
$13.4K Hold
200
﹤0.01% 2476
2023
Q1
$8.6K Buy
+200
New +$10.4K ﹤0.01% 2272
2022
Q4
Sell
-200
Closed -$12K 2291
2022
Q3
$12K Hold
200
﹤0.01% 2029
2022
Q2
$16K Hold
200
﹤0.01% 3509
2022
Q1
$21K Hold
200
﹤0.01% 3367
2021
Q4
$18K Hold
200
﹤0.01% 3388
2021
Q3
$40K Hold
200
﹤0.01% 2735
2021
Q2
$43K Buy
200
+60
+43% +$12.9K ﹤0.01% 2618
2021
Q1
$32K Buy
140
+40
+40% +$9.03K ﹤0.01% 2713
2020
Q4
$18K Buy
+100
New +$20K ﹤0.01% 2312

Other funds holding AIM

CAPTRUST Financial Advisors's AIM Position: Q2 2025 in Review

CAPTRUST Financial Advisors sold out of AIM ImmunoTech (AIM) in Q2 2025, closing a stake of 200 shares — an estimated $2.45K sold.

CAPTRUST Financial Advisors first reported a position in AIM in Q4 2020 and held it in 17 quarters. The position peaked at $43K in Q2 2021. 12 funds tracked by Wall St. Rank hold AIM as of Q2 2025.

  • CAPTRUST Financial Advisors reported no remaining AIM ImmunoTech position as of Q2 2025 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 200 AIM ImmunoTech shares in Q2 2025, an estimated $2.45K.
  • CAPTRUST Financial Advisors first reported a position in AIM ImmunoTech in Q4 2020 and held it in 17 quarters.
  • CAPTRUST Financial Advisors's AIM ImmunoTech position peaked at $43K in Q2 2021.
  • 12 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2025.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2025, filed 15 Aug 2025.